Company Overview

Hero Technologies Inc. (OTC: HENC) is a U.S.-based cannabis-focused company involved in the development of cultivation, processing, and retail operations within the regulated marijuana industry. Based on publicly available disclosures and OTC market filings, the company has pursued opportunities in cannabis production infrastructure, dispensary operations, and vertically integrated cannabis business models. Its activities have primarily centered on establishing licensed operations in selected U.S. states where medical or adult-use cannabis frameworks permit commercial participation.

The company’s business strategy has emphasized expansion through acquisitions, licensing efforts, and subsidiary development rather than large-scale established operating revenue. Public disclosures indicate that Hero Technologies has explored cultivation facilities, dispensary assets, and cannabis-related intellectual property opportunities. The company’s positioning has largely targeted emerging state-regulated cannabis markets where smaller public operators may seek early market entry. Historical information available through OTC filings suggests the company evolved from a shell-oriented corporate structure into a cannabis-sector operating entity through strategic restructuring and acquisition activity. Some historical operational details remain limited due to the scope of publicly available reporting.

Business Operations

Hero Technologies conducts operations primarily through cannabis-related subsidiaries and development entities associated with cultivation and retail licensing efforts. Public filings and corporate announcements have referenced operations or intended operations involving cannabis cultivation facilities, dispensary development, and processing activities. Revenue generation appears intended to come from regulated cannabis sales, cultivation output, and vertically integrated retail operations, although publicly available financial disclosures indicate that portions of the company’s projects have remained in development stages at various times.

The company has referenced assets and interests connected to cannabis operations in multiple U.S. jurisdictions, including projects involving cultivation infrastructure and dispensary licensing. Publicly discussed subsidiaries and affiliated entities have included cannabis operating businesses pursuing local regulatory approvals and market entry initiatives. Available disclosures also reference strategic relationships with local operators and property-based investments tied to cannabis production. However, the operational scale, active production levels, and commercial performance of certain announced projects are difficult to independently verify based on currently available public filings. Data inconclusive based on available public sources.

Strategic Position & Investments

Hero Technologies’ strategic direction has focused on participating in the expanding U.S. regulated cannabis industry through acquisitions, project development, and market-entry investments. The company has publicly discussed efforts to secure cultivation licenses, dispensary opportunities, and vertically integrated operations in states with developing cannabis frameworks. Its strategy appears centered on establishing operational footprints before broader market maturation while leveraging public-market access to support expansion initiatives.

Public disclosures have referenced investments in cannabis cultivation infrastructure and ownership interests tied to licensed cannabis entities. The company has also announced acquisitions and development plans involving cannabis facilities and operational subsidiaries intended to support long-term market participation. Emerging areas of interest have included cannabis processing and retail expansion within regulated jurisdictions. While the company has communicated growth ambitions through corporate releases and OTC disclosures, some initiatives remain difficult to independently confirm regarding operational status, production scale, or revenue contribution. Data inconclusive based on available public sources.

Geographic Footprint

Hero Technologies’ operations and development activities have primarily focused on the United States cannabis market. Public disclosures have referenced activity in states including Michigan, Massachusetts, and other regulated cannabis jurisdictions where cultivation and dispensary licensing opportunities exist. The company is headquartered in the United States, and its operational emphasis has remained domestic rather than international.

The company’s market presence appears concentrated in state-level cannabis opportunities rather than broad multinational operations. Available filings and public announcements do not indicate a significant international operating footprint or material overseas investment platform. While the company has discussed expansion into multiple state-regulated markets, the extent of active operational influence across all announced jurisdictions cannot be fully verified through currently available public records.

Leadership & Governance

Hero Technologies has operated under leadership focused on cannabis-sector expansion, licensing strategy, and acquisition-oriented growth initiatives. Public disclosures and OTC filings indicate that management has emphasized long-term participation in regulated cannabis markets through vertically integrated operations and strategic market entry. Governance information available through public filings is more limited than that of larger SEC-reporting issuers because the company trades on the OTC market and disclosure depth varies over time.

Key executives publicly associated with the company include:

• Gina Serkasevich – Chief Executive Officer
• Christopher P. Foley – Executive Chairman

Additional executive and governance information has appeared periodically in OTC disclosures and corporate filings, though the consistency and depth of reporting have varied. Some historical leadership records and organizational details could not be fully verified across multiple independent public sources.